Validation of the Standardized Outcomes in Nephrology–Life Participation Instrument in People with CKD
Kidney360 · 2026-09 · 7 (9) · 2028-2038
DOI: 10.34067/kid.0000001247 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Kidney360, online erschienen am 06.07.2026. Verfasst von Anastasia Hughes und 18 weiteren Autor:innen. Beteiligte Einrichtung: Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Quality of Life. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Key Points The Standardised Outcomes in Nephrology–Life Participation instrument is valid and reliable to use in patients with CKD not yet requiring KRT. Use of the Standardised Outcomes in Nephrology–Life Participation instrument in clinical trials and publication of results will ensure consistency reporting of life participation in trials in people with CKD.
Background
Life participation has been identified as a critically important core outcome by people with CKD not yet requiring KRT. In this study, we aimed to validate the Standardized Outcomes in Nephrology–Life Participation (SONG-LP) instrument.
Methods
A psychometric evaluation of the SONG-LP was conducted in adults with CKD not yet requiring KRT. The instrument includes four equally weighted domains of life participation including leisure, family, work, and social activities, scored on a five-point Likert scale that specifies frequency over a 1-month recall period from never (zero) to always (four) with a range of zero to four possible (calculated as a mean of the four responses). Internal consistency, test-retest reliability, convergent validity, hypothesis testing, and acceptability were assessed.
Results
In total, 179 participants from 16 countries participated. The SONG-LP instrument demonstrated strong internal consistency (Cronbach α =0.92; 95% confidence interval [CI], 0.89 to 0.94; baseline; McDonald ω =0.93; 95% CI, 0.91 to 0.95; baseline) and strong test-retest reliability over 1 week ( n =165, intraclass correlation coefficient of 0.81; 95% CI, 0.76 to 0.86) with mean scores 2.97±0.91 and 3.07±0.92 at baseline and at week 1, respectively. There was strong positive correlation with the Patient-Reported Outcomes Measurement Information System Ability to Participate in Social Roles and Activities Short Form 8a that assesses a similar construct (0.81; 95% CI, 0.72 to 0.86), and moderate correlation with measures that assess related concepts including Euro Quality of Life-5 Dimension (0.72; 95% CI, 0.63 to 0.79) and Patient-Reported Outcomes Measurement Information System Cognitive Functional Abilities Subset Short Form 4a (0.61; 95% CI, 0.50 to 0.70).
Conclusions
The SONG-LP instrument is a valid, reliable and internally consistent instrument to assess life participation in people with CKD not yet requiring KRT. It can potentially facilitate routine and consistent assessment of life participation in trials and routine clinical care in people with CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
- Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, New South Wales, Australia.
- Department of Kidney and Transplant Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
- Kidney Health Service, Logan General Hospital, Meadowbrook, Queensland, Australia.
- Faculty of Health, Medicine and Behavioural Science, University of Queensland, Brisbane, Queensland, Australia.
- Australasian Kidney Trials Network (AKTN), University of Queensland, Brisbane, Queensland, Australia.
ORCID-Profile: Anastasia Hughes, Cameron Burnett, Yeoungjee Cho, Armando Teixeira-Pinto, Chandana Guha, David W Johnson, Vanessa Kumar, Fergus J Caskey, Jonathan C Craig, Meghan J Elliott, Sharlene Greenwood, Adeera Levin, Amanda Sluiter, Hernan Trimarchi, Bill Wang, Allison Jaure
Förderung
- National Health and Medical Research Council
Zitieren
APA
Hughes, A., Burnett, C., Ju, A., Cho, Y., Teixeira-Pinto, A., Guha, C., Howell, M., Johnson, D. W., Kumar, V., Caskey, F. J., Craig, J. C., Elliott, M. J., Farragher, J., Greenwood, S., Levin, A., Sluiter, A., Trimarchi, H., Wang, B., & Jaure, A. (2026). Validation of the Standardized Outcomes in Nephrology–Life Participation Instrument in People with CKD. Kidney360, 7(9), 2028-2038. https://doi.org/10.34067/kid.0000001247
Vancouver
Hughes A, Burnett C, Ju A, Cho Y, Teixeira-Pinto A, Guha C, et al. Validation of the Standardized Outcomes in Nephrology–Life Participation Instrument in People with CKD. Kidney360. 2026;7(9):2028-2038. doi:10.34067/kid.0000001247
BibTeX
@article{Hughes2026,
author = {Hughes, Anastasia and Burnett, Cameron and Ju, Angela and Cho, Yeoungjee and Teixeira-Pinto, Armando and Guha, Chandana and Howell, Martin and Johnson, David W and Kumar, Vanessa and Caskey, Fergus J and Craig, Jonathan C and Elliott, Meghan J and Farragher, Janine and Greenwood, Sharlene and Levin, Adeera and Sluiter, Amanda and Trimarchi, Hernan and Wang, Bill and Jaure, Allison},
title = {Validation of the Standardized Outcomes in Nephrology–Life Participation Instrument in People with CKD},
journal = {Kidney360},
year = {2026},
volume = {7},
number = {9},
pages = {2028--2038},
doi = {10.34067/kid.0000001247}
}
EUVIMED